Microbix Biosystems Inc.
MBXBF · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $46,774 | $43,230 | $69,820 | $71,331 |
| - Cash | $12,963 | $11,606 | $13,488 | $9,986 |
| + Debt | $6,397 | $6,645 | $5,823 | $7,735 |
| Enterprise Value | $40,207 | $38,269 | $62,155 | $69,080 |
| Revenue | $25,394 | $16,515 | $19,076 | $18,593 |
| % Growth | 53.8% | -13.4% | 2.6% | – |
| Gross Profit | $15,392 | $7,481 | $11,125 | $11,044 |
| % Margin | 60.6% | 45.3% | 58.3% | 59.4% |
| EBITDA | $6,205 | $1,957 | $3,328 | $5,659 |
| % Margin | 24.4% | 11.9% | 17.4% | 30.4% |
| Net Income | $3,520 | -$39 | $1,789 | $1,630 |
| % Margin | 13.9% | -0.2% | 9.4% | 8.8% |
| EPS Diluted | 0.026 | -0 | 0.013 | 0.012 |
| % Growth | 8,633.3% | -102.4% | 9.6% | – |
| Operating Cash Flow | $4,348 | -$1,095 | $3,465 | $2,107 |
| Capital Expenditures | -$1,907 | -$1,016 | -$2,026 | -$1,303 |
| Free Cash Flow | $2,441 | -$2,111 | $1,440 | $804 |